Details for New Drug Application (NDA): 022548
✉ Email this page to a colleague
The generic ingredient in ZYMAXID is gatifloxacin. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the gatifloxacin profile page.
Summary for 022548
Tradename: | ZYMAXID |
Applicant: | Abbvie |
Ingredient: | gatifloxacin |
Patents: | 0 |
Suppliers and Packaging for NDA: 022548
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYMAXID | gatifloxacin | SOLUTION/DROPS;OPHTHALMIC | 022548 | NDA | Allergan, Inc. | 0023-3615 | 0023-3615-01 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-01) / 1 mL in 1 BOTTLE, DROPPER |
ZYMAXID | gatifloxacin | SOLUTION/DROPS;OPHTHALMIC | 022548 | NDA | Allergan, Inc. | 0023-3615 | 0023-3615-25 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-25) / 2.5 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.5% | ||||
Approval Date: | May 18, 2010 | TE: | AT | RLD: | Yes |
Expired US Patents for NDA 022548
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | ZYMAXID | gatifloxacin | SOLUTION/DROPS;OPHTHALMIC | 022548-001 | May 18, 2010 | ⤷ Subscribe | ⤷ Subscribe |
Abbvie | ZYMAXID | gatifloxacin | SOLUTION/DROPS;OPHTHALMIC | 022548-001 | May 18, 2010 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription